Dec 02, 2021 8:08am EST Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan
Nov 10, 2021 5:00pm EST Medexus Pharmaceuticals Reports Financial and Operational Results for the Three- and Six-Month Periods Ending September 30, 2021
Nov 01, 2021 9:27am EDT Medexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan
Oct 26, 2021 8:30am EDT Medexus to Present at the Benzinga Global Small Cap Conference on October 28, 2021
